|
441 |
Sustained Clinical Response to Ivosidenib in Previously Treated Patients with Advanced Intrahepatic Cholangiocarcinoma Harboring an IDH1 R132 Mutation: Two Case Reports Enthalten in Case reports in oncology Bd. 17, 2024, Nr. 1: 753-762. 10 S.
|
|
|
442 |
Impact of Extreme Prematurity, Chorioamnionitis, and Sepsis on Neonatal Monocyte Characteristics and Functions Enthalten in Journal of innate immunity Bd. 16, 2024, Nr. 1: 470-488. 19 S.
|
|
|
443 |
Immunkombination plus TACE mit handhabbarem Sicherheitsprofil Enthalten in Onkologische Welt Bd. 15, 2024, Nr. 05: 311-311
|
|
|
444 |
PFS-Risiko um 84 % reduziert Enthalten in Onkologische Welt Bd. 15, 2024, Nr. 05: 302-302
|
|
|
445 |
Study design approaches for future active-controlled HIV prevention trials Enthalten in Statistical communications in infectious diseases Bd. 15, 2024, Nr. 1. 17 S.
|
|
|
446 |
First-Line Lenvatinib plus Pembrolizumab for Hepatocellular Carcinoma: Post hoc Analysis of Japanese Patients from the Phase 3 LEAP-002 Trial Enthalten in Liver cancer Bd. 14, 2024, Nr. 4: 365-377. 13 S.
|
|
|
447 |
Effect of Curcuminoids on Contrast-Induced Acute Kidney Injury after Elective Coronary Angiography or Intervention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study Enthalten in Cardiorenal Medicine Bd. 14, 2024, Nr. 1: 160-166. 7 S.
|
|
|
448 |
A Systematic Search and Review of Registered Pharmacological Therapies Investigated to Improve Outcomes after a Stroke Enthalten in Cerebrovascular diseases / Extra Bd. 14, 2024, Nr. 1: 158-164. 7 S.
|
|
|
449 |
A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394 Enthalten in Liver cancer Bd. 13, 2024, Nr. 4: 389-400. 12 S.
|
|
|
450 |
Rapid Antidepressant and Antisuicidal Effects of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression With or Without Low-Grade Inflammation Enthalten in Pharmacopsychiatry 20.12.2024
|
|